Neuronetics, Inc. (STIM)
1.52
+0.03
(+2.01%)
USD |
NASDAQ |
Apr 02, 16:00
1.54
+0.02
(+1.32%)
After-Hours: 04:17
Neuronetics EPS Diluted (Quarterly) : -0.1041 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InspireMD, Inc. | -0.1428 |
| Tactile Systems Technology, Inc. | 0.4615 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.206M |
| Revenue (Quarterly) | 41.78M |
| Total Expenses (Quarterly) | 48.94M |
| Enterprise Value | 165.33M |
| Gross Profit Margin (Quarterly) | 50.99% |
| Profit Margin (Quarterly) | -17.25% |
| Earnings Yield | -39.32% |
| Normalized Earnings Yield | -39.32 |